
CNN @CNN
Vaccine advisers to the FDA narrowly voted in favor of Pfizer’s RSV vaccine for adults over the age of 60, paving the way for approval of the first nation’s RSV vaccine, despite some safety concerns https://t.co/v9IBEQdEd0 — PolitiTweet.org